Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by GoBBson May 29, 2020 2:41pm
126 Views
Post# 31089164

keep posting misleading bs NewCrapO

keep posting misleading bs NewCrapOMay 13th MD&A "Due to the impact of COVID19 on our workforce and ongoing operations, "we are currently unable to predict the timing of our BLA resubmission."  Thats sure doesn't indicate 1H2020 does it ? Can you even read ? here try again ....

Due to the impact of COVID19 on our workforce and ongoing operations, we are currently unable to predict the timing of our BLA resubmission.
Due to the impact of COVID19 on our workforce and ongoing operations, we are currently unable to predict the timing of our BLA resubmission.
Due to the impact of COVID19 on our workforce and ongoing operations, we are currently unable to predict the timing of our BLA resubmission.
Due to the impact of COVID19 on our workforce and ongoing operations, we are currently unable to predict the timing of our BLA resubmission.
<< Previous
Bullboard Posts
Next >>